ArticleAntimicrobial agents and chemotherapy2015
In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- A Calcineurin Inhibitor as an Enhancer ofACS omega · 2026Article
- Article
- Candidiasis byJournal of fungi (Basel, Switzerland) · 2021Article
- In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B againstPharmaceutics · 2021Article
- Article
- In Vitro Synergistic Interactions of Isavuconazole and Echinocandins againstAntibiotics (Basel, Switzerland) · 2021Article
- Rezafungin-Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins.Journal of fungi (Basel, Switzerland) · 2020Review
- Caenorhabditis elegans as a Model System To Assess Candida glabrata,Antimicrobial agents and chemotherapy · 2020Article
- Identification of Growth Inhibitors of the Fish PathogenFrontiers in microbiology · 2020Article
- Article
- Therapeutic tools for oral candidiasis: Current and new antifungal drugs.Medicina oral, patologia oral y cirugia bucal · 2019Review
- First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.Folia microbiologica · 2018Article
- Methodologies forMicrobial cell (Graz, Austria) · 2018Review
- Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.Journal of medical case reports · 2016Article
- Article
- First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.Memorias do Instituto Oswaldo Cruz · 2016Article
- Dose escalation studies with caspofungin against Candida glabrata.Journal of medical microbiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anidulafungin, caspofungin, and micafungin killing activities against Candida glabrata, Candida bracarensis, and Candida nivariensis were evaluated by the time-kill methodology. The concentrations assayed were 0.06, 0.125, and 0.5 μg/ml, which are achieved in serum. Anidulafungin and micafungin required between 13 and 26 h to reach the fungicidal endpoint (99.9% killing) against C. glabrata and C. bracarensis. All echinocandins were less active against C. nivariensis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.